Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.

Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L.

Cancer Cell. 2016 Jul 11;30(1):27-42. doi: 10.1016/j.ccell.2016.05.004. Epub 2016 Jun 16.

PMID:
27321955
2.

Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.

Hemdan T, Malmström PU, Jahnson S, Segersten U.

J Urol. 2015 Dec;194(6):1575-81. doi: 10.1016/j.juro.2015.06.085. Epub 2015 Jun 26.

PMID:
26119672
3.

The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.

Hemdan T, Lindén M, Lind SB, Namuduri AV, Sjöstedt E, de Ståhl TD, Asplund A, Malmström PU, Segersten U.

Br J Cancer. 2014 Sep 9;111(6):1180-7. doi: 10.1038/bjc.2014.427. Epub 2014 Jul 29.

4.

Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.

Vedder MM, Márquez M, de Bekker-Grob EW, Calle ML, Dyrskjøt L, Kogevinas M, Segersten U, Malmström PU, Algaba F, Beukers W, Ørntoft TF, Zwarthoff E, Real FX, Malats N, Steyerberg EW.

PLoS One. 2014 Jun 6;9(6):e96849. doi: 10.1371/journal.pone.0096849. eCollection 2014.

5.

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.

Andersson G, Wennersten C, Gaber A, Boman K, Nodin B, Uhlén M, Segersten U, Malmström PU, Jirström K.

BMC Urol. 2014 May 12;14:36. doi: 10.1186/1471-2490-14-36.

6.

The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer.

Segersten U, Spector Y, Goren Y, Tabak S, Malmström PU.

Urol Oncol. 2014 Jul;32(5):613-8. doi: 10.1016/j.urolonc.2013.11.001. Epub 2014 Jan 14.

PMID:
24439061
7.

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

Boman K, Larsson AH, Segersten U, Kuteeva E, Johannesson H, Nodin B, Eberhard J, Uhlén M, Malmström PU, Jirström K.

Br J Cancer. 2013 Jun 11;108(11):2321-8. doi: 10.1038/bjc.2013.215. Epub 2013 May 7.

8.

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.

Boman K, Segersten U, Ahlgren G, Eberhard J, Uhlén M, Jirström K, Malmström PU.

BMC Urol. 2013 Apr 8;13:17. doi: 10.1186/1471-2490-13-17.

9.

Tumour expression of bladder cancer-associated urinary proteins.

Lindén M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, Lind SB, Malmström PU.

BJU Int. 2013 Aug;112(3):407-15. doi: 10.1111/j.1464-410X.2012.11653.x. Epub 2013 Mar 7.

10.

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.

Fristrup N, Birkenkamp-Demtröder K, Reinert T, Sanchez-Carbayo M, Segersten U, Malmström PU, Palou J, Alvarez-Múgica M, Pan CC, Ulhøi BP, Borre M, Ørntoft TF, Dyrskjøt L.

Am J Pathol. 2013 Feb;182(2):339-49. doi: 10.1016/j.ajpath.2012.10.017. Epub 2012 Nov 28.

PMID:
23201130
11.

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.

Dyrskjøt L, Reinert T, Novoradovsky A, Zuiverloon TC, Beukers W, Zwarthoff E, Malats N, Real FX, Segersten U, Malmström PU, Knowles M, Hurst C, Sorge J, Borre M, Orntoft TF.

Br J Cancer. 2012 Oct 9;107(8):1392-8. doi: 10.1038/bjc.2012.412. Epub 2012 Sep 13.

12.

Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.

Fristrup N, Ulhøi BP, Birkenkamp-Demtröder K, Mansilla F, Sanchez-Carbayo M, Segersten U, Malmström PU, Hartmann A, Palou J, Alvarez-Múgica M, Zieger K, Borre M, Ørntoft TF, Dyrskjøt L.

Am J Pathol. 2012 May;180(5):1824-34. doi: 10.1016/j.ajpath.2012.01.023. Epub 2012 Mar 24.

PMID:
22449953
13.

Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.

Lindén M, Lind SB, Mayrhofer C, Segersten U, Wester K, Lyutvinskiy Y, Zubarev R, Malmström PU, Pettersson U.

Proteomics. 2012 Jan;12(1):135-44. doi: 10.1002/pmic.201000810. Epub 2011 Dec 2.

PMID:
22065568
14.

An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.

Yavari N, Andersson-Engels S, Segersten U, Malmstrom PU.

Can J Urol. 2011 Aug;18(4):5778-86. Review.

PMID:
21854709
15.

Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma.

Nord H, Segersten U, Sandgren J, Wester K, Busch C, Menzel U, Komorowski J, Dumanski JP, Malmström PU, Díaz de Ståhl T.

Int J Cancer. 2010 Mar 15;126(6):1390-402. doi: 10.1002/ijc.24954.

16.

Impact of thawing on RNA integrity and gene expression analysis in fresh frozen tissue.

Botling J, Edlund K, Segersten U, Tahmasebpoor S, Engström M, Sundström M, Malmström PU, Micke P.

Diagn Mol Pathol. 2009 Mar;18(1):44-52. doi: 10.1097/PDM.0b013e3181857e92.

PMID:
19214109
17.

Molecular genetics of bladder cancer: an update.

Díaz De Ståhl T, Segersten U, Malmström PU.

Minerva Urol Nefrol. 2008 Dec;60(4):205-16. Review.

PMID:
18923358
18.

Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.

Segersten U, Björklund P, Hellman P, Akerström G, Westin G.

Clin Endocrinol (Oxf). 2007 Mar;66(3):399-404.

PMID:
17302875
19.

25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.

Segersten U, Holm PK, Björklund P, Hessman O, Nordgren H, Binderup L, Akerström G, Hellman P, Westin G.

Breast Cancer Res. 2005;7(6):R980-6. Epub 2005 Oct 6.

20.

Parathyroid glands in calcium regulation and human disease.

Akerström G, Hellman P, Hessman O, Segersten U, Westin G.

Ann N Y Acad Sci. 2005 Apr;1040:53-8. Review.

PMID:
15891005
Items per page

Supplemental Content

Loading ...
Write to the Help Desk